Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy

Asian Pacific Journal of Allergy and Immunology

Volumn 25, Issue 1, 2007, Pages 7-11

  Gulen, Figen ^a   Zeyrek, Dost ^a   Can, Demet ^b   Altinoz, Serdar ^a   Koksoy, Huseyin ^a   Demir, Esen ^a   Tanac, Remziye ^a  

^a Aegean University School of Medicine   (Turkey)

^b DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; STEROID;

ARTICLE; ASTHMA; CHILD; CHILD CARE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DERMATOPHAGOIDES; FEMALE; FESCUE; FRAXINUS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OLIVE; PREVALENCE; SENSITIZATION; SKIN TEST;

ALLERGENS; ANIMALS; ASTHMA; CAUSALITY; CHILD; DESENSITIZATION, IMMUNOLOGIC; DUST; FEMALE; FESTUCA; FRAXINUS; HUMANS; HYPERSENSITIVITY; MALE; PYROGLYPHIDAE; SKIN TESTS;

EID: 34250831452     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bousquet J, Lockey RF, Malling HJ. WHO Position Paper. Allergen immunotherapy: tberapeutical vaccines for allergic diseases. Allergy 1998; 53 (Suppl. 44): 1-42.
2. Malling H-J, Abreu-Nogueira J, Alvarez-Cuesta E, et al. Local immunotherapy. Position Paper by the working group on local immunotherapy of the EAACI Subcommittee and the ESPACI Immunotherapy Subcommittee. Allergy 1998; 53: 933-44.
3. Tabar AI, Muro MD, Garcia BE, et al. Dermatophagoides pleronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy. J Invest Allergol Clin Immunol 1999; 9: 155-64.
4. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001; 107: 87-93.
5. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-75.
6. Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002; 57: 306-12.
7. Bachert C, van Cauwenberge P. The WHO ARIA (allergic rhinitis and its impact on asthma) initiative. Chem Immunol Allergy 2003; 82:119-26.
8. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109: 251-56.
9. Des Roches A, Paradis LM, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997; 99: 450-53.
10. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children mono-sensitized to house dust mite by specific immunotherapy. A six year follow-up study. Clin Exp Allergy 2001; 31: 1392-97.
11. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in mono-sensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31: 1295-302.
12. Asero R. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004; 133: 49-54.
13. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institute of Health. National Heart, Lung and Blood Institute. Publication No: 02-3659, Revised 2002.
14. Dreborg S, Frew A. Allergen standardization and skin tests. EAACI position paper. Allergy 1993; 48 (Suppl. 14): 49-82.
15. Cools M, van Bever HP, Weyler JJ, Stevens WJ. Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic either to house-dust mite or to both house-dust mite and grass pollen. Allergy 2000; 55: 468-73.
16. Kuehr J, Frischer T, Meinert R, et al. Sensitization to mite allergens is a risk factor for early and late onset of asthma and for persistence of asthmatic signs in children. J Allergy Clin Immunol 1995; 95 (3): 655-62.
17. Kjelimann N. Natural course of asthma and allergy in childhood. Pediatr Allergy Immunol 1994; 5 (Suppl.6): 13-18.
18. Platts-Mills TAE, Vervloet D, Thomas Wit, Aalbersee RC. Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997; 100: 1-24.
19. Gruber W, Eber E, Mileder P, Modl M, Weinhandl E, Zach MS. Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of pediatric patients. Clin Exp Allergy 1999; 29 (2): 176-81.
20. Van Bever HP, Bosmans J, De Clerck LS, Stevens WJ. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen. Allergy 1988; 43 (5): 378-85.
21. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.
22. Akdis CA, Blaser K. Mechanism of allergen-specific immunotherapy. Allergy 2002; 55: 522-30.
23. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
24. + T cells from allergic individuals. J Exp Med 1993; 178: 2123-30.
25. Ebner C, Siemann U, Bohle B, et al. Immunological changes during specific immunotherapy of grass pollen allergy. Reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T cell clones specific for Ph1 p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27: 1007-15.
26. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33: 206-10.
27. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004; 59: 1205-10.
28. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403-6.
29. + regulatory T cells. Nat Immunol 2003; 4: 330-6.
30. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
31. + suppressor T cells: more questions than answers. Nat Rev Immunol; 2002; 2: 389-400.